Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.74
Delayed Data
As of 12:48pm ET
 +0.14 / +2.50%
Today’s Change
1.45
Today|||52-Week Range
9.40
+8.92%
Year-to-Date

Today’s Trading

Previous close5.60
Today’s open5.59
Day’s range5.56 - 5.74
Volume87,324
Average volume (3 months)592,870
Market cap$168.0M
Dividend yield--
Data as of 12:48pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-0.77%
Earnings growth (this year)+66.03%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.38
Price/Book6.71

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...+0.02+0.92%
ALRNAileron Therapeutics...+0.20+1.70%
ADMPAdamis Pharmaceutica...+0.10+1.96%
OCXOncoCyte Corp+0.05+0.77%
Data as of 1:02pm ET, 09/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$799.0K
Annual profit (last year)-$29.7M
Net profit margin-3,721.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts